SB 446 Hawaii Senate · 2024 Regular Session

RELATING TO PRESCRIPTION DIGITAL THERAPEUTICS.

Summary
Requires the Department of Health to conduct a study to determine the feasibility of implementing a pilot program to integrate prescription digital therapeutic products approved by the federal Food and Drug Administration in outpatient treatment programs for persons with substance use disorder and persons with opioid use disorder in the State. Requires a report to the Legislature. Effective 12/31/2050. (SD1)
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
Governor
Introduced Jan 20, 2023 Last action Dec 11, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
8
Key actions
2
Committee
4
Feb 17, 2023
Committee
Reported from HHS (Stand. Com. Rep. No. 459) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.
upper
Feb 6, 2023
Upper · Passed
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Moriwaki, Shimabukuro; Aye(s) with reservations: none ; 1 No(es): Senator(s) Awa; and 0 Excused: none.
upper
Feb 3, 2023
Upper · Passed
The committee(s) on HHS has scheduled a public hearing on 02-06-23 1:00PM; Conference Room 225 & Videoconference.
upper
Jan 25, 2023
Committee
Referred to HHS, WAM.
upper
Jan 20, 2023
Introduced
Introduced.
upper
4 primary · 2 co-sponsors

Sponsors